Cardiff Oncology, Inc. (CRDF) Discusses Advances in First-Line Treatment for RAS-Mutated Metastatic Colorectal Cancer and Clinical Data on PLK1 Inhibitor Transcript
Corroborated by 1 source from 1 publisher
globalhealth3h ago
TL;DR
According to seekingalpha.com, cardiff Oncology, Inc.